Management of GERD with Globus Sensation

Rationale for Dose Escalation

The American Gastroenterological Association recommends twice-daily PPI dosing for patients with inadequate response to once-daily therapy, despite limited clinical trial data supporting this approach 3, 1

Allow 8-12 weeks on twice-daily dosing before declaring treatment failure, as globus sensation and extraesophageal GERD symptoms often require 2-3 months of adequate acid suppression before improvement occurs 1, 2
The standard 4-8 week trial used for typical heartburn is insufficient for globus symptoms 1, 2
Ensure the patient takes omeprazole 30-60 minutes before meals (not at bedtime) for optimal acid suppression 2, 5

Perform upper endoscopy to assess for erosive esophagitis, hiatal hernia, and Barrett's esophagus 1
If endoscopy is normal or shows only mild disease, perform 96-hour wireless pH monitoring OFF PPI therapy to confirm true GERD versus functional disorder 1
Consider high-resolution esophageal manometry if pH testing is negative, as globus can result from subtle motility disorders 4, 1

The American Gastroenterological Association guidelines specifically state that patients whose symptoms have not adequately responded to once-daily dosing should receive twice-daily PPI therapy before being considered treatment failures 3, 1
Increase omeprazole to 40 mg twice daily (before breakfast and dinner) for 8-12 weeks, as this patient has failed standard once-daily therapy and requires dose escalation before pursuing diagnostic workup 1, 2

Do not add metoclopramide - it is specifically recommended against (Grade D) for GERD management due to unfavorable risk-benefit profile 3
Do not add nighttime H2-receptor antagonists - there is no evidence of improved efficacy when adding H2RAs to twice-daily PPI therapy 3, 4
Do not empirically add baclofen or prokinetics without objective testing confirming the mechanism of symptoms 1

Mistiming PPI administration: Taking omeprazole at bedtime rather than before meals dramatically reduces efficacy 2, 5
Premature diagnostic testing: Performing endoscopy before completing an adequate therapeutic trial wastes resources 1
Assuming globus equals GERD: Up to 50% of patients with globus sensation may have functional disorders or reflux hypersensitivity rather than true acid reflux 1
Polypharmacy without evidence: Adding multiple agents (H2RAs, prokinetics, alginates) without objective testing leads to unnecessary medication burden and cost 3, 1

Weight loss if BMI >25 - this may prevent or postpone the need for continued acid suppression 3
Elevate head of bed 6-8 inches if the patient has nighttime symptoms 3
Avoid specific triggers only if the patient identifies consistent symptom provocation (alcohol, coffee, spicy foods) 3

Attempt de-escalation after 3-6 months of symptom control by stepping down to once-daily dosing, then potentially to on-demand therapy 1, 2
If erosive esophagitis or Barrett's esophagus is found, the patient requires indefinite daily PPI therapy 1, 2